Home/Filings/4/0001169245-21-000042
4//SEC Filing

Hanson Kristopher 4

Accession 0001169245-21-000042

CIK 0001169245other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 6:09 PM ET

Size

4.9 KB

Accession

0001169245-21-000042

Insider Transaction Report

Form 4
Period: 2021-05-20
Hanson Kristopher
Vice President, Head of Legal
Transactions
  • Award

    Common Stock

    2021-05-20$2.80/sh+1,088$3,0462,087 total
Footnotes (1)
  • [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001789970

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 6:09 PM ET
Size
4.9 KB